T.E.S.T. has participated in each SensUs competition since 2016. See what the topics over the years have been and what each generation of T.E.S.T. has worked on:
Creatinine is a biomarker used to assess kidney function and is commonly used to monitor kidney disease patients. This year’s theme is especially innovative since the biomarker should be measured continuously.
GFAP is a biomarker for Traumatic Brain Injury (TBI). It is important that the severity of TBI can be diagnosed rapidly, so that patients can receive the appropriate treatment, and permanent damage can be avoided.
Interleukin-6 is a biomarker for acute inflammation and it can reach high concentrations in case of sepsis, a life-threatening condition triggered by infection. IL-6 is an important marker for early diagnosis and monitoring of sepsis.
Click here to learn more about the team of 2022!
Hemagglutin is a biomarker for Influenza A. It can be found on the surface of influenza viruses and is essential to its infectivity. The usage of biosensors for detecting influenza A has the potential to mitigate the spread of this virus.
Click here to learn more about the team of 2021!
Valproate (VPA) is a drug used for treating epilepsy, bipolar disorder and spinal muscular atrophy. A biosensor that measures VPA is needed for personalizing VPA treatment, which can improve treatment.
Click here to learn more about the team of 2020!
Adalimumab is biological drug for patients suffering from rheumatoid arthritis (RA), which affects around 1% of the world population. By measuring the concentrations of adalimumab, it is possible to enhance the management of the disease in a more efficient and effective manner.
Click here to learn more about the team of 2019!
The broad application of antibiotic drugs in our society has led to the emergence of Anti-Microbial Resistance (AMR). The use of a vancomycin biosensor has the potential to improve patient outcomes by enabling the precise dosing of medication, thus enhancing treatment efficacy and efficient usage of the drug.
Click here to learn more about the team of 2018!
NT-probNP is a key biomarker for heart failure (HF). With a prevalence of approximately 1% of the population, HF constitutes a significant public health concern in both developed and developing nations. Measurement of NT-proBNP would facilitate the early diagnosis and monitoring of heart failure.
Click here to learn more about the team of 2017!
Creatinine is a biomarker for the detection of kidney failure. Since creatinine is a waste product that the kidneys filter out of the bloodstream, its detection allows patients to easily and rapidly monitor their kidney function, having overview of their own health.
Click here to learn more about the team of 2016!